The impact of AI on life sciences for in-house IP teams

Gareth Jones, Vice President of IP at BenevolentAI discusses the implications of the convergence between tech and pharma for in-house IP teams.

About

IAM Video

IAM
IAM Video
  • Posted 13 January 2020
  • Duration 1:26 min
  • Language English

Tags